Positive regulation of natural killer cell mediated immunity

pathway activity — cross-omics
GO:0002717Cross-omicsRNA → SHRNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Positive regulation of natural killer cell mediated immunity pathway is significantly associated with the shRNA dependency of multiple genes, with the BLOOD_Myeloma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are KRT85, SH2D3C, and TEC, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The box plot shows the strongest association, KRT85 grouped by Positive regulation of natural killer cell mediated immunity-low versus -high activity in BLOOD_Myeloma.

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_MyelomaKRT85 →-0.322-0.173.001.00935
OVARYSH2D3C →+0.162+0.107.004.00134
LARGE_INTESTINETEC →+0.205+0.191.003<.00134
BONEPRDM4 →+0.318+0.210.007.00134
LIVERPALB2 →-0.319-0.253.009.00234
BONEZFX →-0.463-0.184<.001.00634
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

KRT85 by Positive regulation of natural killer cell mediated immunity activity — BLOOD_Myeloma

Box plot of KRT85 in Positive regulation of natural killer cell mediated immunity-low vs -high samples in BLOOD_Myeloma.

Explore this box plot interactively →

Exploration